Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolus (EOLS) Change in Receivables: 2019-2025

Historic Change in Receivables for Evolus (EOLS) over the last 7 years, with Sep 2025 value amounting to $4.9 million.

  • Evolus' Change in Receivables rose 107.13% to $4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.5 million, marking a year-over-year decrease of 33.77%. This contributed to the annual value of $19.6 million for FY2024, which is 105.88% up from last year.
  • Per Evolus' latest filing, its Change in Receivables stood at $4.9 million for Q3 2025, which was up 415.24% from $958,000 recorded in Q2 2025.
  • In the past 5 years, Evolus' Change in Receivables ranged from a high of $9.5 million in Q2 2024 and a low of -$1.3 million during Q1 2021.
  • For the 3-year period, Evolus' Change in Receivables averaged around $3.3 million, with its median value being $2.5 million (2023).
  • In the last 5 years, Evolus' Change in Receivables plummeted by 153.32% in 2021 and then surged by 2,435.76% in 2024.
  • Over the past 5 years, Evolus' Change in Receivables (Quarterly) stood at $1.5 million in 2021, then grew by 21.09% to $1.8 million in 2022, then slumped by 91.44% to $151,000 in 2023, then skyrocketed by 2,435.76% to $3.8 million in 2024, then soared by 107.13% to $4.9 million in 2025.
  • Its Change in Receivables was $4.9 million in Q3 2025, compared to $958,000 in Q2 2025 and $823,000 in Q1 2025.